Perfluoroalkyl substances and lipid concentrations in the blood: A systematic review of epidemiological studies

Sci Total Environ. 2022 Dec 1:850:158036. doi: 10.1016/j.scitotenv.2022.158036. Epub 2022 Aug 13.

Abstract

Background: Perfluoroalkyl substances (PFAS) are widely used synthetic aliphatic compounds. This systematic review aims to assess PFAS associations with low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), total cholesterol (TC) and total triglyceride (TG) concentrations in human populations.

Method: We systematically searched four online databases, PubMed, Scopus, Embase, and Cochrane Library for relevant peer-reviewed English language articles published until July 2021. Additional relevant articles identified were also included in the search results. We categorised populations into adults (≥18 years old) and children. Primary findings were the associations between PFAS concentrations and LDL, HDL, TC, and TG concentrations in the serum, plasma, or whole blood; secondary findings were the associations between PFAS concentrations and the odds of lipid-related health outcomes. Quantitative synthesis was done by vote counting of the effect directions between concentrations of PFAS and lipids/health outcomes, repeated on articles with sample size >1000. Sign tests were performed to assess the statistical significance of the differences between positive and negative associations. Sensitivity analysis was performed by separating out articles with populations having high concentrations of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). Quality was assessed with the STROBE checklist and NHBLI Study Quality Assessment Tool.

Results: A total of 58 articles were included for review. There was evidence that PFAS exposure is associated with higher concentrations of LDL, HDL, and TC, particularly for PFOA-LDL, PFOA-TC, PFOS-TC, and PFNA-LDL. Associations between PFAS and TG tended to be negative, especially for perfluoroundecanoic acid (PFUnDA). Associations between PFAS concentration and the odds of secondary outcomes generally supported a positive association between PFAS and cholesterol concentrations.

Conclusion: We found evidence of associations between the concentrations of some PFAS-lipid pairs in human populations. Future research should be conducted on the less well-studied PFAS to explore their effects on human health and in regions where such studies are currently lacking. (300 words).

Keywords: High-density lipoprotein cholesterol; Low-density lipoprotein cholesterol; Perfluoroalkyl substances; Total cholesterol; Total triglycerides.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Alkanesulfonic Acids*
  • Caprylates
  • Child
  • Cholesterol
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Environmental Pollutants*
  • Epidemiologic Studies
  • Fluorocarbons*
  • Humans
  • Lipids
  • Triglycerides

Substances

  • Alkanesulfonic Acids
  • Caprylates
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Environmental Pollutants
  • Fluorocarbons
  • Lipids
  • Triglycerides
  • perfluorooctanoic acid
  • Cholesterol
  • perfluorooctane sulfonic acid